Introduction
The genomes of eukaryotic cells are constantly being subjected to exogenous and endogenous genotoxic stresses. Damage resulting from exposure to these stresses threatens cell survival and can lead to cancer, as well as other genetic diseases. To preserve genomic integrity and ensure that an accurate copy of the genome is passed on to subsequent generations, cells have evolved a core surveillance machinery known as cell cycle checkpoints. These checkpoints sense damaged or abnormally structured DNA and coordinate cell cycle progression with DNA repair. In cases when damage is excessive or repair is unfavorable, the cell death machinery is activated to eliminate damaged cells (Zhou and Elledge, 2000; Melo and Toczyski, 2002; Niida and Nakanishi, 2006) .
In mammalian cells, the DNA damage response is regulated by two primary signaling pathways. The ataxia telangiectasia mutated (ATM)-mediated pathway is activated in response to DNA-damaging agents that induce double-strand breaks (Shiloh, 2003) , whereas the ATM and Rad3-related (ATR)-dependent pathway responds to a broad spectrum of genotoxic stresses, including those that inhibit replication and induce single-strand DNA breaks or bulky DNA lesions (Abraham, 2001; Bakkenist and Kastan, 2004) . Certain DNA-damaging agents, such as the topoisomerase II poison, etoposide, activate both the ATM-and ATRdependent pathways by inducing both double-and single-strand breaks in DNA (Montecucco and Biamonti, 2007) . Upon activation, ATM and ATR act in collaboration with members of the Rad family in order to relay the damage signal to downstream transducer and effector proteins (Chen et al., 2001; Weiss et al., 2002; Zou et al., 2002; Niida and Nakanishi, 2006) . Three members of the Rad family, Rad9, Rad1 and Hus1, form a heterotrimeric clamp that acts as a putative sensor for DNA damage (Volkmer and Karnitz, 1999; Burtelow et al., 2001) . Another member of the Rad family, Rad17, along with the four small subunits of the replication factor C complex, is responsible for loading the Rad9-Rad1-Hus1 (9-1-1) complex onto DNA in response to various types of DNA damage (Rauen et al., 2000; Lindsey-Boltz et al., 2001; Bermudez et al., 2003) .
As the 9-1-1 complex plays an apical role in the DNA damage response, loss of a functional complex affects many downstream checkpoint pathways. Impaired function of the 9-1-1 complex results in defects in cell cycle arrest, an increase in chromosomal abnormalities and increased sensitivity to genotoxic stresses (Weiss et al., 2000 (Weiss et al., , 2003 Kinzel et al., 2002; Wang et al., 2003; Bao et al., 2004; Hopkins et al., 2004; Dang et al., 2005) . Moreover, loss of Rad9 or Hus1 results in embryonic lethality, which is, at least in part, attributable to widespread apoptosis during embryogenesis (Weiss et al., 2000; Hopkins et al., 2004 (Weiss et al., 2000) . In addition to playing a key role in the regulation of DNA damage checkpoints, Rad9 also has been shown to induce apoptosis through its interaction with the prosurvival Bcl-2 and Bcl-xL proteins (Komatsu et al., 2000b; Yoshida et al., 2002 Yoshida et al., , 2003 Ishii et al., 2005) . Furthermore, Rad9 can be cleaved by caspase-3, resulting in the disruption of the 9-1-1 complex and the release of the BH3-containing fragment of Rad9 into the cytosol where it binds to Bcl-xL to potentiate the apoptotic response (Lee et al., 2003) . These studies demonstrate that the members of the 9-1-1 complex are not only important for initiating cell cycle checkpoints in response to DNA damage but that these proteins also play a role in the regulation of apoptosis.
Apoptosis is mediated through two major pathways: the extrinsic pathway, which is activated by ligation of death receptors, and the intrinsic or stress-induced mitochondrial pathway. The members of the Bcl-2 family play a central role in the regulation of apoptosis induced through the mitochondrial pathway (Cory et al., 2003) . The Bcl-2 family consists of both antiand pro-apoptotic members. Proteins such as Bcl-2 and Bcl-xL are anti-apoptotic and thus prevent the activation of apoptosis through the mitochondrial pathway. The pro-apoptotic Bcl-2 family members can be subdivided into the multidomain proteins, including Bax and Bak, and the BH3-only proteins, which include Bim and Puma, among others. The BH3-only proteins act as sensors for damage signals and induce apoptosis by neutralizing the anti-apoptotic proteins or by directly activating the multidomain pro-apoptotic proteins of the Bcl-2 family to release apoptogenic factors from the mitochondria (Strasser, 2005) . Therefore, the members of the Bcl-2 family ultimately control the decision of whether a cell is to live or die on the basis of the relative ratio of anti-to pro-apoptotic proteins (Oltvai and Korsmeyer, 1994; Adams and Cory, 2007) .
Although loss of Hus1 results in increased sensitivity to DNA damage-induced apoptosis, the molecular mechanism by which this occurs has yet to be elucidated. In this study, we demonstrate that loss of Hus1 sensitizes cells to etoposide treatment through the upregulation of the BH3-only proteins, Bim and Puma. Furthermore, loss of Hus1 results in a defect in the binding of Rad9 to chromatin and the release of Rad9 into the cytosol, which in turn enhances the interaction of Rad9 with Bcl-2 to amplify the apoptotic response.
Results

Loss of Hus1 sensitizes cells to etoposide-induced apoptosis
Knockout of Hus1 results in cell cycle checkpoint defects and enhanced cell death in response to DNA damage induced by hydroxyurea and ultraviolet radiation (Weiss et al., 2000 (Weiss et al., , 2002 (Weiss et al., , 2003 . In this study, we examine the sensitivity of Hus1-deficient cells to etoposide, one of the most potent drugs used for cancer therapy (Montecucco and Biamonti, 2007) . To determine whether the loss of Hus1 would sensitize cells to etoposide-induced cell death, Hus1 þ / þ p21 À/À and Hus1 À/À p21 À/À MEFs were treated with increasing doses of etoposide for 24 h. Measurement of cell death by a trypan blue exclusion assay revealed that knockout of Hus1 greatly enhanced the dose-dependent susceptibility of MEFs to etoposide (Figure 1a) . Consistently, the hypersensitivity of Hus1-deficient cells to etoposideinduced cell death also occurred in a time-dependent manner ( Figure 1b) .
To determine whether the increase of cell death in Hus1-deficient cells is due to enhanced induction of apoptosis, the activation of caspase-3, as well as the cleavage of its downstream substrate, poly (ADP-ribose) polymerase (PARP), was examined by immunoblot analysis. Hus1
À/À cells exhibited a robust induction of caspase-3 processing, which correlated with PARP cleavage, upon 24 h treatment with 12.5 mg/ml etoposide that was further enhanced at a higher dose (Figure 1c ). In contrast, Hus1 þ / þ p21 À/À cells showed only slight activation of caspase-3 and minimal PARP cleavage even upon treatment with the highest dose of etoposide ( Figure 1c) . Induction of apoptosis in response to etoposide treatment was further analysed by the examination of nuclear morphology for chromatin condensation and nuclear fragmentation. As shown in Figures 1d and e, Hus1-deficient cells were almost three times more sensitive to etoposide-induced apoptosis. Taken together, these results suggest that MEFs that lack Hus1 are not only sensitive to hydroxyurea and ultraviolet radiation as previously described but are also sensitive to DNA damage induced by topoisomerase II poisons, such as the chemotherapeutic drug etoposide.
Loss of Hus1 enhances Bim and Puma expressions at both the protein and mRNA levels in response to DNA damage As our results indicate that the loss of Hus1 sensitizes cells to etoposide-induced apoptosis, the expression levels of members of the Bcl-2 family were examined (Figure 2a) . In response to etoposide treatment, the expression levels of anti-apoptotic Bcl-2-like proteins and pro-apoptotic multidomain proteins remained relatively stable in both Hus1
Hus1
À/À p21 À/À MEFs. It can be noted that the basal level of Bcl-xL was higher in Hus1 À/À p21 À/À cells than that in Hus1 þ / þ p21 À/À cells, presumably to neutralize the elevated Bax expression in cells lacking Hus1 (Weiss et al., 2000) . Interestingly, the expression of the BH3-only proteins, Bim and Puma, was induced after etoposide treatment. Whereas the expression of these proteins was only slightly induced and peaked at 24 h in (Weiss et al., 2002) were treated with etoposide for varying time points, and the expression of Bim and Puma was examined. Expression of Hus1, but not control GFP, significantly reduced the etoposide-induced expressions of Bim and Puma in Hus1
À/À MEFs. These results indicate that loss of Hus1 results in the upregulation of Bim and Puma in response to etoposide-induced DNA damage.
The activity of BH3-only proteins can be regulated by various means, including transcriptional upregulation, post-translational modification, proteasomal degrada- Hours etoposide (6.25 µg/ml) 
Percent apoptotic
MEFs were treated with 6.25 mg/ml etoposide for varying time points and subjected to the trypan blue exclusion assay (mean ± s.d.; n ¼ 3). (c) Cells were treated as in panel a. Total cell lysate was normalized for protein content and subjected to SDS-PAGE/immunoblot analysis.
MEFs were treated with 6.25 mg/ml etoposide for 0 or 48 h. Apoptosis was determined by the examination of nuclear morphology. Arrows indicate apoptotic nuclei.
and Hus1 À/À p21 À/À MEFs were treated with 6.25 mg/ml etoposide for the times indicated. The percentage of apoptotic cells was quantified based on nuclear morphology (mean ± s.d.; n ¼ 3).
tion and sequestration to cytoskeletal components (Puthalakath and Strasser, 2002; Willis and Adams, 2005) . To examine whether the induction of Bim and Puma expressions observed in Hus1-deficient cells is regulated at the transcriptional level after exposure to etoposide, Hus1
À/À cells were treated with etoposide in the presence of a transcriptional inhibitor, actinomycin D; a translational inhibitor, cycloheximide; or control DMSO (dimethyl sulfoxide). As shown in Figure 3a , treatment with either actinomycin D or cycloheximide abrogated the expression of Bim, as well as Puma, even in the presence of etoposide. In contrast, the expression of these BH3-only proteins was significantly induced in response to etoposide treatment in the control DMSO-treated cells (Figure 3a ). This indicates that the upregulation of both Bim and Puma expressions Bcl-2 
and Hus1 À/À p21 À/À MEFs were treated with (a) 6.25 mg/ml etoposide, (b) 500 nM camptothecin (CPT) or (c) 50 mM hydroxyurea (HU) for the indicated time points. Total cell lysate was prepared and analysed by SDS-PAGE/immunoblot using the indicated antibodies. points, presumably due to induction of cell death. It can be noted that a greater upregulation of Bim, especially BimS, the most potent isoform, and Puma mRNAs was observed in Hus1-deficient cells than that in Hus1-wildtype cells. Consistently, when cells were treated with a higher dose of etoposide for a shorter time course, a clear induction of Bim and Puma mRNAs occurred in a time-dependent manner, with more dramatic increases seen in Hus1
À/À cells (Figures 3d and e) . It can be noted that the protein expression levels (Figure 2a ) of Bim and Puma in Hus1
À/À cells after etoposide treatment are higher than their mRNA levels (Figures 3b and c) , suggesting that the etoposide-mediated upregulation of Bim and Puma is regulated through both transcriptional and post-transcriptional mechanisms.
Knockdown of Bim and Puma confers resistance to etoposide-induced apoptosis in Hus1-deficient cells Our results clearly show that loss of Hus1 not only results in the upregulation of Bim and Puma expressions but also promotes caspase-3 activation and cell death induced by etoposide treatment. As BH3-only proteins play a key role in the initiation of apoptosis (Huang and Strasser, 2000; Puthalakath and Strasser, 2002; Willis and Adams, 2005) , we examined whether the upregulation of Bim and Puma expressions is responsible for sensitizing Hus1-deficient cells to etoposide treatment. As a dramatic induction of all three isoforms of Bim was observed in response to etoposide treatment, we first examined whether the inhibition of Bim expression would suppress DNA damage-induced cell death in Hus1
À/À MEFs. Transfection of siRNA specific for Bim abrogated its expression, even upon treatment with etoposide ( Figure 4a ). Knockdown of Bim expression resulted in a decrease in PARP cleavage (Figure 4a ) and partial resistance to DNA damage-induced cell death (Figure 4b ), as compared with green fluorescent protein, GFP siRNA (siGFP) or mock-transfected cells. These results suggest that the upregulation of Bim expression contributes to the sensitivity of Hus1-deficient cells to etoposide-induced apoptosis. We next examined whether the upregulation of Puma expression is also involved in sensitizing Hus1-deficient cells to etoposide treatment. To this end, a lentiviral delivery system was used to transduce Hus1
À/À MEFs with short hairpin RNA (shRNA) targeting Puma or Bim, or a control scrambled shRNA. Whereas etoposide treatment resulted in the induction of Bim and Puma expressions in control shScrambled-expressing cells, the upregulation of these proteins was suppressed by their respective shRNA (Figure 4c) . Consistent with the siBim results shown in Figure 4a , expression of shBim suppressed etoposide-induced apoptosis (Figures 4c  and d) . Moreover, knockdown of Puma expression significantly suppressed etoposide-induced caspase-3 activation and apoptosis, as compared with control cells (Figures 4c and d) . As knockdown of either Bim or Puma alone only partially suppressed etoposide-induced cell death, we next examined whether Bim and Puma are acting redundantly or synergistically to induce apoptosis in response to etoposide treatment. To this end, shBimexpressing Hus1
À/À MEFs were infected with lentivirus expressing shRNA targeting Puma, which resulted in efficient knockdown of Puma expression (Figure 4c ). Importantly, knockdown of both Bim and Puma expressions resulted in further inhibition of caspase-3 processing and apoptosis, when compared with Hus1
À/À cells expressing shBim or shPuma alone (Figures 4c and d) . Taken together, these results indicate that Bim and Puma cooperate in sensitizing Hus1-deficient cells to etoposide-induced apoptosis.
Loss of Hus1 enhances the binding of Rad9 to Bcl-2 to potentiate the apoptotic response It has been shown that DNA damage promotes the binding of the 9-1-1 checkpoint complex to chromatin to initiate the DNA damage response and facilitate the activation of downstream proteins (Zhou and Elledge, 2000; Parrilla-Castellar et al., 2004) . Consistently, Rad9 binding to chromatin was enhanced in Hus1-wild-type cells in a time-dependent manner after etoposide treatment (Figure 5a ). In contrast, chromatin-bound Rad9 was barely detectable in Hus1-deficient cells, although a slight increase was noticeable after etoposide treatment. These results are consistent with previous findings, which show that HU-and ultraviolet radiation-induced binding of Rad9 to chromatin is decreased in Hus1 À/À cells (Zou et al., 2002) . Taken together, these results indicate that loss of Hus1 results in a defect in the binding of Rad9 to chromatin in response to DNA damage.
We and others have previously shown that Rad9 interacts with Bcl-2 or Bcl-xL through a BH3-like domain within its N-terminus to promote apoptosis after DNA damage (Komatsu et al., 2000a, b; Yoshida et al., 2002 Yoshida et al., , 2003 Lee et al., 2003; Ishii et al., 2005) . These results indicate that Rad9 not only has functions in the nucleus as a member of a DNA damage checkpoint complex but also in the cytosol as an inducer of apoptosis. Therefore, the effect of loss of Hus1 on the intracellular localization of Rad9 was examined. Consistent with previous studies , Rad9 was detected in both the nuclear and cytosolic fractions of Hus1 þ / þ p21 À/À cells when analysed by subcellular fractionation (Figure 5b) . Moreover, etoposide treatment resulted in Rad9 accumulation and hyperphosphorylation in the nucleus of Hus1 (Figure 5b ). In contrast, Rad9 was primarily detected in the cytosolic fraction of Hus1-deficient cells and remained hypophosphorylated even upon DNA damage (Figure 5b ). These results suggest that Rad9 chromatin binding and hyperphosphorylation are Hus1-dependent.
To determine whether Rad9 binds to Bcl-2 family members during apoptosis, the interaction between Rad9 and Bcl-2 was examined in Hus1 þ / þ p21 À/À and Hus1 À/À p21 À/À cells in response to etoposide treatment. As the majority of Rad9 was detected in the cytosolic fraction of Hus1-deficient cells, co-immunoprecipitation of cytosolic Rad9 with Bcl-2 was performed. Although etoposide treatment enhanced the interaction of Rad9 with Bcl-2, a significant amount of cytosolic Rad9 was bound to Bcl-2 even in the absence of DNA damage (Figure 5c ). Thus, it is possible that subcellular fractionation using a hypotonic buffer may alter the conformation or localization of Rad9 and Bcl-2, which affects their interaction. Indeed, it has been shown that Rad9 can leak from the nucleus during subcellular fractionation even in the absence of DNA damage . To confirm the interaction of Rad9 and Bcl-2, the co-immunoprecipitation was repeated using whole cell lysates. As Figure 5d shows, a minimal amount of Rad9 was bound to Bcl-2 in the absence of DNA damage, regardless of Hus1 status. Treatment with etoposide resulted in an induction of Rad9 binding to Bcl-2, which was much greater in Hus1-deficient cells than in Hus1-wild-type cells. These results suggest that, in response to DNA damage, Rad9 may also contribute to the enhanced sensitivity of Hus1-deficient cells through its interaction with anti-apoptotic Bcl-2 family members.
We therefore examined whether Rad9 cooperates with Bim and Puma to sensitize Hus1-deficient cells to etoposide-induced apoptosis. Hus1
À/À MEFs stably expressing shBim and shPuma were infected with lentivirus expressing shRNA targeting Rad9. Indeed, knockdown of Rad9 resulted in further inhibition of caspase-3 activation, as compared with the shBim-and shPuma-expressing cells (Figures 6a and b) . Consistently, suppression of Rad9 expression in the shBim-and shPuma-expressing cells conferred further resistance to etoposide-induced cell death (Figure 6c ). Taken together, these results indicate that Rad9 acts in collaboration with Bim and Puma to sensitize Hus1-deficient cells to etoposide-induced apoptosis.
Discussion
In this study, we have demonstrated that loss of Hus1 results in the upregulation of the BH3-only proteins, Bim and Puma, which is partially responsible for sensitizing Hus1-deficient cells to etoposide-induced apoptosis. In addition, we found that in the absence of Hus1, Rad9 functions as a BH3-only protein and cooperates with Bim and Puma to promote apoptosis in response to etoposide treatment. There are currently two models for the activation of apoptosis by the Bcl-2 family members: the direct model and the hierarchy model (Galonek and Hardwick, 2006 ). The direct model proposes that BH3-only proteins have varying levels of potency owing to their ability to bind various Bcl-2-like family members. Thus, Bim, Puma and tBid are highly potent as they can bind all of the anti-apoptotic Bcl-2 family members, whereas Noxa and Bad are less potent as they can only bind to a subset of the Bcl-2-like proteins. In the hierarchy model, on the other hand, Bim and Puma, as well as tBid, are more potent as they Figure 5 Rad9 is predominantly detected in the cytoplasm of Hus1-deficient cells where it binds to Bcl-2 in response to DNA damage. (a) Hus1 þ / þ p21 À/À and Hus1 À/À p21 À/À MEFs were treated with 12.5 mg/ml etoposide for 0, 2 or 8 h and subjected to subcellular fractionation. The resulting chromatin-bound and soluble fractions were analysed by SDS-PAGE/immunoblot using antibodies specific for Rad9 and RPA as a control. (b) Hus1 þ / þ p21 À/À and Hus1 À/À p21 À/À MEFs were treated with 12.5 mg/ml etoposide or control DMSO for 12 h and subjected to subcellular fractionation. The resulting cytosolic (Cyt) and nuclear (Nuc) fractions, along with whole cell lysate (WCL) were analysed by SDS-PAGE/immunoblot. (c and d) Hus1 þ / þ p21 À/À and Hus1 À/À p21 À/À MEFs were treated with 12.5 mg/ml etoposide or control DMSO for 12 h. (c) The cytosolic fractions of Hus1 þ / þ p21 À/À and Hus1 À/À p21 À/À MEFs were subjected to immunoprecipitation in the absence or presence of anti-Bcl-2 monoclonal antibody. The resulting immune complexes were analysed by SDS-PAGE/immunoblot. (d) WCL was subjected to immunoprecipitation with anti-Bcl-2 or control anti-Flag monoclonal antibodies. The resulting immunocomplexes and WCL were analysed by SDS-PAGE/immunoblot. The amount of Rad9 in the immunocomplexes was quantified and normalized to cytosolic (c) or total (d) Rad9. The levels of Bcl-2-bound Rad9 are listed relative to those of untreated Hus1 À/À p21 À/À cells, which were set as 1.00.
act downstream of the other BH3-only proteins and the Bcl-2-like proteins, and they can bind directly to the multidomain pro-apoptotic proteins, resulting in their activation and the induction of apoptosis. This model suggests that loss of both Bim and Puma expressions would result in complete inhibition of apoptosis mediated through the intrinsic pathway. Our results show that knockdown of both Bim and Puma expressions diminishes the hypersensitivity of Hus1-deficient cells to etoposide-induced apoptosis, indicating that both Bim and Puma indeed play a central role in the activation of this programmed cell death pathway.
Interestingly, suppression of Rad9 expression in the Bim and Puma double-knockdown cells resulted in further inhibition of DNA damage-induced apoptosis. Therefore, our data argue in favor of the direct model and suggest that it is the ratio of the BH3-only proteins to the Bcl-2 like proteins that regulates apoptosis. Our results demonstrate that Bim and Puma mRNA expressions are induced by etoposide treatment (Figure 3 ). Among known transcription factors, FoxO3a, p53 and E2F1 are the best candidates for regulators of Bim and Puma expression in response to etoposide treatment, as these transcription factors have MEFs stably expressing control shRNA, shBim and shPuma, or shBim and shPuma plus shRad9 were treated with 12.5 mg/ml etoposide for 0, 24 or 48 h. Cell death was determined by a trypan blue exclusion assay (mean ± s.d.; n ¼ 3).
been shown to upregulate Bim and Puma in response to DNA damage (Dijkers et al., 2000; Nakano and Vousden, 2001; Sunters et al., 2003; Hershko and Ginsberg, 2004; Yang et al., 2006 Rad9 has been shown to play a role in multiple cellular processes, including regulation of cell cycle checkpoints, transcriptional activation of p53 targets, initiation of DNA repair and when DNA repair is unfavorable, induction of apoptosis (Lieberman, 2006) . It has been suggested that the primary function of Rad9 is to act as a sensor in the DNA damage response pathway to promote survival by initiating cell cycle arrest and facilitating DNA repair (Loegering et al., 2004; Brandt et al., 2006) . Thus, it is not surprising that the loss of Rad9 sensitizes cells to DNA damage, as these cells lack the ability to activate appropriate cell cycle checkpoints and DNA repair. On the other hand, Rad9 may function as a pro-apoptotic factor in cells with unrepairable, excessively damaged DNA or a disrupted 9-1-1 complex, such as through loss of Hus1. Hus1-deficient cells have a defective cell cycle checkpoint, thus making them more sensitive to DNA damage. In the absence of Hus1, Rad9 was found to be mostly located in the cytosol, where it formed perinuclear foci and associated with Bcl-2 in response to DNA damage ( Figure 5 and data not shown). These results suggest that loss of Hus1 results in an abrogation of the nuclear functions of Rad9 and an augmentation of its pro-apoptotic functions.
Taken together, the results presented in this study indicate that the 9-1-1 complex plays a critical role in the suppression of etoposide-induced apoptosis by regulating the induction of the BH3-only proteins, Bim and Puma. Loss of Hus1 results in enhanced upregulation of these BH3-only proteins, which initiate mitochondrial apoptosis in response to DNA damage. Moreover, disruption of the 9-1-1 complex, by loss of Hus1, switches Rad9 from functioning as a mediator of cell cycle checkpoints to an inducer of apoptosis. Thus, the 9-1-1 complex may act as a checkpoint sensor to decide whether a cell should survive or undergo apoptosis in response to DNA damage. (Weiss et al., 2000) , as well as Hus1 (Weiss et al., 2002) , were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 1.0 mM L-glutamine, 0.1 mM MEM non-essential amino acids, 100 mg/ml streptomycin and 100 U/ml penicillin. The 21-nucleotide siRNA duplexes targeting Bim and GFP were synthesized and purified by Dharmacon (Lafayette, CO, USA). The siRNA sequence targeting mouse Bim mRNA was 5 0 -AAUUACAACUGUUACGCUUUA-3 0 . The siRNA specific for GFP has previously been described (Hirai and Wang, 2002) . Hus1
Materials and methods
Cell culture and transfection
À/À MEFs were transfected with 10 mg of siRNA per 1 Â 10 6 cells using the Nucleofector system. After transfection, the cells were allowed to recover for 36 h. The medium, containing any cell that may have died due to transfection, was removed and replaced with treatment medium containing control DMSO or etoposide.
The pLKO.1-based lentiviral shRNAs targeting Bim (TRCN0000009692), Puma (TRCN0000009710) and Rad9 (TRCN0000012638) were purchased from Open Biosystems (Huntsville, AL, USA). The pLKO.1-based scrambled control shRNA vector was purchased from Sigma (St Louis, MO, USA). Recombinant lentivirus was produced by co-transfecting the appropriate shRNA plasmid with the ViraPower Packaging Mix (Invitrogen, Carlsbad, CA, USA) into 293FT cells. The resulting supernatant containing shRNA-expressing lentivirus was used to transduce Hus1
À/À MEFs according to the manufacturer's protocol.
Analysis of cell death and apoptosis
Cell death was assessed by the trypan blue exclusion assay. Apoptosis was scored by the presence of nuclear chromatin condensation and DNA fragmentation, and evaluated by fluorescence microscopy. Briefly, the cells were harvested, fixed in 4% paraformaldehyde for 10 min at room temperature and washed with phosphate-buffered saline. Cell nuclei were stained with 0.5 mg/ml bis-benzimide trihydrochloride (Hoechst 33258, Molecular Probes, Eugene, OR, USA). At least 200 cells were counted for each sample and percentage of apoptosis was calculated [(apoptotic nuclei)/(all nuclei) Â 100]. The induction of apoptosis was analysed using a caspase-3 activity assay (Sigma) and by examination of caspase-3 processing and PARP cleavage by SDS-PAGE (polyacrylamide gel electrophoresis)/immunoblot analysis.
Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was performed using the Qiagen (Valencia, CA, USA) OneStep RT-PCR system according to the manufacturer's recommendations. The primers for Bim and GAPDH have been described earlier (Wong et al., 2005) . The primers for Puma are 5 0 -GTGATCCGGACACGAA GACT-3 0 and 5 0 -GACTCTAAGTGCTGCTGGGC-3 0 .
Subcellular fractionation and co-immunoprecipitation Subcellular fractionation was performed as described earlier (Wang et al., 1996) . Chromatin fractionation was carried out as described earlier (Mendez and Stillman, 2000) . Co-immunoprecipitation of Rad9 with Bcl-2 was performed as described earlier with minor modifications (Yoshida et al., 2002 (Yoshida et al., , 2003 . Briefly, whole cell lysate was prepared in 1% NP-40 lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM Na 3 VO 4 , 1mM PMSF (Phenylmethylsulfonyl fluoride), 1 mM DTT, 10 mM NaF, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 10 mg/ml pepstatin A). One milligram of the lysate was pre-cleared by incubation with protein G agarose beads for 1 h at 4 1C. The precleared lysate was then incubated with anti-Bcl-2 (BD Pharmingen, San Diego, CA, USA Cat no. 554218) or anti-Flag monoclonal antibody as a negative control overnight at 4 1C. The immunocomplexes were then incubated with protein G agarose beads for 1.5 h at 4 1C. After extensive washing in lysis buffer, the resulting immunocomplexes were subjected to SDS-PAGE/immunoblot analysis with anti-Rad9 polyclonal antibody. For co-immunoprecipitation analysis of the cytosolic fraction, NP-40, SDS and NaCl were added to a final concentration of 1, 0.1% and 150 mM, respectively, after fractionation.
